Working paper

Evidence on orphan drugs

Status
Status: Commission completed
Project no.
GA21-01
Last updated

Report documents

  1. Extract of the working paper

    Evidence on orphan drugs

    published on
    Document type
    PDF document, 243 kB, EN, not accessible
  2. Working paper

    Evidence on orphan drugs

    published on
    Document type
    PDF document, 835 kB, EN, not accessible

Press releases

Orphan drugs: privilege of "fictitious" added benefit not justified

Drugs for rare diseases should also undergo a regular benefit assessment procedure at market entry. This is shown by a current IQWiG analysis.

Project details

Project no.
GA21-01
Report type
Working paper
Status
Commission completed
Department/Division
Drug Assessment

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form